SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

11317	Companies
251455	Keywords
180564	Articles
137279	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 06/16/2025 at 22:40, 1 year 4 months ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 06/15/2025 at 17:27, 1 year 4 months ago

Sanofi's Dupixent Surpasses Xolair in Phase 4 Study for Chronic Rhinosinusitis with Asthma

Sanofi Dupixent Phase 4 Study CRSwNP Asthma
BRIEF

published on 06/15/2025 at 17:27, 1 year 4 months ago

Dupixent de Sanofi surpasse Xolair dans une étude de phase 4 pour la rhinosinusite chronique avec asthme

Sanofi Dupixent CRSwNP Étude De Phase 4 Asthme
PRESS RELEASE

published on 06/15/2025 at 17:22, 1 year 4 months ago

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
Dupixent outperformed Xolair in treating chronic rhinosinusitis with nasal polyps and coexisting asthma, showing superior efficacy across all key endpoints in a phase 4 study presented at EAACI

Dupixent Phase 4 Study Asthma Xolair Chronic Rhinosinusitis
BRIEF

published on 06/09/2025 at 23:14, 1 year 5 months ago

Sanofi Releases May 2025 Voting Rights and Shares Data

Voting Rights Shares Regulatory Compliance France Sanofi
BRIEF

published on 06/09/2025 at 23:14, 1 year 5 months ago

Sanofi publie les données relatives aux droits de vote et aux actions de mai 2025

Actions Droit De Vote Conformité Réglementaire France Sanofi
PRESS RELEASE

published on 06/09/2025 at 23:09, 1 year 5 months ago

Sanofi: Information concerning the total number of voting rights and shares - May 2025
Sanofi discloses total voting rights and shares information in compliance with French regulations. Details available on Sanofi's investor relations website

Voting Rights Shares French Regulations Investor Relations Sanofi
PRESS RELEASE

published on 06/09/2025 at 23:09, 1 year 5 months ago

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mai 2025
Informations sur les droits de vote et actions de Sanofi conformément aux règlementations financières en vigueur. Détails disponibles sur le site Internet de Sanofi

Autorité Des Marchés Financiers Droits De Vote Actions Règlement Financier Sanofi
BRIEF

published on 06/09/2025 at 07:05, 1 year 5 months ago

Sanofi prépare la distribution anticipée de Beyfortus pour contrer le VRS

Production Sanofi AstraZeneca VRS Beyfortus
BRIEF

published on 06/09/2025 at 07:05, 1 year 5 months ago

Sanofi prepares early distribution of Beyfortus to counter RSV

Production Sanofi AstraZeneca VRS Beyfortus

Accesswire

Published on 11/11/2026 at 03:30, 5 hours 28 minutes ago

CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 8 hours 18 minutes ago

Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 9 hours 28 minutes ago

CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 9 hours 58 minutes ago

Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 9 hours 58 minutes ago

Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary

View all ACCESSWIRE

EQS Group

Published on 11/11/2026 at 08:31, 27 minutes ago

Delivery Hero SE: Notice to the Bondholders of the EUR 500 million Convertible Bonds due 2029 (ISIN DE000A3MP437 – Common Code 238511097 – German Securities Code (WKN) A3MP43)
Published on 11/11/2026 at 08:30, 27 minutes ago

Delivery Hero SE: Notice to the Bondholders of the EUR 1,000 million Convertible Bonds due 2030 (ISIN DE000A30V5R1 – Common Code 258943848 – German Securities Code (WKN) A30V5R)
Published on 11/11/2026 at 08:30, 28 minutes ago

Delivery Hero SE: Notice to the Bondholders of the EUR 750 million Convertible Bonds due 2028 (ISIN DE000A3H2WQ0 – Common Code 220637387 – German Securities Code (WKN) A3H2WQ)
Published on 11/11/2026 at 08:30, 28 minutes ago

aap Implantate AG: Management Board refines 2026 forecast and provides first outlook for 2027 – Ambition 2030: Revenue of at least EUR 21 million with an EBITDA margin of 17.5% to 22.5%
Published on 11/11/2026 at 08:30, 28 minutes ago

Delivery Hero SE: Notice to the Bondholders of the EUR 875 million Convertible Bonds due 2027 (ISIN DE000A254Y92 – Common Code 210751831 – German Securities Code (WKN) A254Y9)

Les Echos

Published on 11/10/2026 at 18:00, 14 hours 58 minutes ago

Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 15 hours 13 minutes ago

Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:40, 15 hours 18 minutes ago

Production du 3ième trimestre 2026
Published on 11/10/2026 at 17:35, 15 hours 23 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 15 hours 26 minutes ago

CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.

View all LES ECHOS COMFI WIRE